172 related articles for article (PubMed ID: 31512598)
1. Multiple docking analysis and
Halder ST; Dhorajiwala TM; Samant LR
Int J Mycobacteriol; 2019; 8(3):229-236. PubMed ID: 31512598
[TBL] [Abstract][Full Text] [Related]
2. Disease Burden and Current Therapeutical Status of Leprosy with Special Emphasis on Phytochemicals.
Swain SS; Sahoo G; Mahapatra PK; Panda SK
Curr Top Med Chem; 2022; 22(19):1611-1625. PubMed ID: 34503409
[TBL] [Abstract][Full Text] [Related]
3. Molecular docking and simulation study for synthesis of alternative dapsone derivative as a newer antileprosy drug in multidrug therapy.
Swain SS; Paidesetty SK; Dehury B; Sahoo J; Vedithi SC; Mahapatra N; Hussain T; Padhy RN
J Cell Biochem; 2018 Dec; 119(12):9838-9852. PubMed ID: 30125973
[TBL] [Abstract][Full Text] [Related]
4. [Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene].
Kai M
Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):221-6. PubMed ID: 15508724
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a potential lead compound for treating leprosy with dapsone resistance mutation in M. leprae folP1.
Nisha J; Ramanathan K; Nawaz Khan F; Dhanasekaran D; Shanthi V
Mol Biosyst; 2016 Jun; 12(7):2178-88. PubMed ID: 27120972
[TBL] [Abstract][Full Text] [Related]
6. Computational Modelling of Dapsone Interaction With Dihydropteroate Synthase in Mycobacterium leprae; Insights Into Molecular Basis of Dapsone Resistance in Leprosy.
Chaitanya V S; Das M; Bhat P; Ebenezer M
J Cell Biochem; 2015 Oct; 116(10):2293-303. PubMed ID: 25833404
[TBL] [Abstract][Full Text] [Related]
7. Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene.
Kai M; Matsuoka M; Nakata N; Maeda S; Gidoh M; Maeda Y; Hashimoto K; Kobayashi K; Kashiwabara Y
FEMS Microbiol Lett; 1999 Aug; 177(2):231-5. PubMed ID: 10474189
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of natural compounds on Dihydropteroate synthase of
Khan M; Khan S; Bushara NZA; Ali R; Tabassum Z; Ishrat R; Marouf HA; Sherwani S; Mirza S; Haque S
J Biomol Struct Dyn; 2023; 41(23):13857-13872. PubMed ID: 37070201
[TBL] [Abstract][Full Text] [Related]
9. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
[TBL] [Abstract][Full Text] [Related]
10. A theoretical study of chemical bonding and topological and electrostatic properties of the anti-leprosy drug dapsone.
Rajendran ND; Mookan N; Samuel I; Mookan SB; Munusamy G; Gurudeeban S; Kaliamurthi S
J Mol Model; 2020 May; 26(6):138. PubMed ID: 32415338
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of the Mycobacterium leprae folP1 gene and dapsone resistance.
Nakata N; Kai M; Makino M
Antimicrob Agents Chemother; 2011 Feb; 55(2):762-6. PubMed ID: 21115799
[TBL] [Abstract][Full Text] [Related]
12. Dapsone resistance does not appear to be associated with a mutation in the dihydropteroate synthase-2 gene of Mycobacterium leprae.
Gillis TP; Williams DL
Indian J Lepr; 1999; 71(1):11-8. PubMed ID: 10439322
[TBL] [Abstract][Full Text] [Related]
13. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
[TBL] [Abstract][Full Text] [Related]
14. Ribonucleotide reductase as a drug target against drug resistance Mycobacterium leprae: A molecular docking study.
Mohanty PS; Bansal AK; Naaz F; Gupta UD; Dwivedi VD; Yadava U
Infect Genet Evol; 2018 Jun; 60():58-65. PubMed ID: 29454978
[TBL] [Abstract][Full Text] [Related]
15. Dapsone resistance in Mycobacterium leprae.
Gillis TP; Williams DL
Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
[TBL] [Abstract][Full Text] [Related]
16. A drug-resistant leprosy case detected by DNA sequence analysis from a relapsed Mexican leprosy patient.
Lopez-Roa RI; Fafutis-Morris M; Masanori M
Rev Latinoam Microbiol; 2006; 48(3-4):256-9. PubMed ID: 18293659
[TBL] [Abstract][Full Text] [Related]
17. Dihydropteroate synthase of Mycobacterium leprae and dapsone resistance.
Williams DL; Spring L; Harris E; Roche P; Gillis TP
Antimicrob Agents Chemother; 2000 Jun; 44(6):1530-7. PubMed ID: 10817704
[TBL] [Abstract][Full Text] [Related]
18. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance.
Waters MF; Pearson JM; Rees RJ
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850
[No Abstract] [Full Text] [Related]
19. In vivo activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with dapsone, against Mycobacterium leprae.
Dhople AM
Int J Antimicrob Agents; 2002 Jan; 19(1):71-4. PubMed ID: 11814771
[TBL] [Abstract][Full Text] [Related]
20. Does dapsone resistance really matter in the MDT era?
Ji B
Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322
[No Abstract] [Full Text] [Related]
[Next] [New Search]
